AstraZeneca Finalizes Equity Investment, Research Collaboration with Cellectis

Posted on by admin

Joint venture aims to develop up to 10 new cell and gene therapy products targeting areas with high unmet medical needs.

Leave a Reply

Your email address will not be published. Required fields are marked *